US20040147998A1 - Differentially coated stent - Google Patents

Differentially coated stent Download PDF

Info

Publication number
US20040147998A1
US20040147998A1 US10/350,704 US35070403A US2004147998A1 US 20040147998 A1 US20040147998 A1 US 20040147998A1 US 35070403 A US35070403 A US 35070403A US 2004147998 A1 US2004147998 A1 US 2004147998A1
Authority
US
United States
Prior art keywords
coating
stent
areas
therapeutic
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/350,704
Inventor
John Nolting
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Vascular Inc
Original Assignee
Medtronic Vascular Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Vascular Inc filed Critical Medtronic Vascular Inc
Priority to US10/350,704 priority Critical patent/US20040147998A1/en
Assigned to MEDTRONIC AVE, INC. reassignment MEDTRONIC AVE, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NOLTING, JOHN E.
Publication of US20040147998A1 publication Critical patent/US20040147998A1/en
Application status is Abandoned legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08Materials for coatings
    • A61L29/085Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A61F2002/91541Adjacent bands are arranged out of phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • A61F2230/0013Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606Coatings
    • A61L2300/608Coatings having two or more layers
    • A61L2300/61Coatings having two or more layers containing two or more active agents in different layers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/901Method of manufacturing prosthetic device

Abstract

The present invention provides a stent that is differentially coated to accommodate areas of high strain. A therapeutic coating is applied to only those areas of the stent that do not experience high strain. This allows a therapeutic coating to be chosen for its elution characteristics, for example, rather than for its ability to withstand high strain. An elastic coating may be applied to the areas of high strain. The elastic coating may or may not include a therapeutic agent.

Description

    TECHNICAL FIELD
  • This invention relates generally to biomedical stents. More specifically, the invention relates to stents that are differentially coated to accommodate areas of high strain. [0001]
  • BACKGROUND OF THE INVENTION
  • Stents are cylindrical-shaped devices that are radially expandable to hold open a segment of a vessel or other anatomical lumen after implantation into the body lumen. Various types of stents are in use, including expandable and self-expanding stents. Expandable stents generally are conveyed to the area to be treated on balloon catheters or other expandable devices. For insertion, the stent is positioned in a compressed configuration along the delivery device, for example crimped onto a balloon that is folded or otherwise wrapped about a guide wire that is part of the delivery device. After the stent is positioned across the lesion, it is expanded by the delivery device, causing the length of the stent to contract and the diameter to expand. For a self-expanding stent, commonly a sheath is retracted, allowing expansion of the stent. [0002]
  • Stents are used in conjunction with balloon catheters in a variety of medical therapeutic applications, including intravascular angioplasty. For example, a balloon catheter device is inflated during PTCA (percutaneous transluminal coronary angioplasty) to dilate a stenotic blood vessel. The stenosis may be the result of a lesion such as a plaque or thrombus. After inflation, the pressurized balloon exerts a compressive force on the lesion, thereby increasing the inner diameter of the affected vessel. The increased interior vessel diameter facilitates improved blood flow. [0003]
  • Soon after the procedure, however, a significant proportion of treated vessels restenose. To prevent restenosis, short flexible cylinders, or stents, constructed of metal or various polymers, are implanted within the vessel to maintain lumen size. The stents act as a scaffold to support the lumen in an open position. Various configurations of stents include a cylindrical tube defined by a mesh, interconnected stents or like segments. Some exemplary stents are disclosed in U.S. Pat. No. 5,292,331 to Boneau, U.S. Pat. No. 6,090,127 to Globerman, U.S. Pat. No. 5,133,732 to Wiktor, U.S. Pat. No. 4,739,762 to Palmaz and U.S. Pat. No. 5,421,955 to Lau. [0004]
  • Stent insertion may cause undesirable reactions such as inflammation, infection, thrombosis, and proliferation of cell growth that occludes the passageway. Stents have been used with coatings to deliver drugs or other therapeutic agents at the site of the stent that may assist in preventing these conditions. The coatings must be bioengineered to control the release of highly potent and potentially toxic drugs. [0005]
  • The choice of a coating may be limited by its mechanical attributes. For example, a polymer with a desired drug elution profile may be brittle and prone to cracking in areas of the stent that experience high strain while the stent is being compressed during manufacture or expanded during delivery into the target vessel. Alternatively, a coating that erodes at a desired rate, thereby delivering drug at a known, controlled rate, may also be brittle or otherwise unable to withstand the strains of compression or expansion. Cracking of a coating in high-strain areas may cause extensive delamination of the coating from other areas of the stent, resulting in an unknown amount of drug being delivered. [0006]
  • Therefore it would be desirable to have an improved, differentially coated stent that accommodates these areas of high strain and overcomes the above and other disadvantages. [0007]
  • SUMMARY OF THE INVENTION
  • One aspect of the present invention is a system for treating a vascular condition, comprising a catheter; a stent coupled to the catheter, the stent including a stent framework, the stent framework including areas of high strain; and a therapeutic coating disposed on the stent framework and avoiding the areas of high strain. The system may further comprise an elastic coating disposed on at least the high strain areas of the stent framework. [0008]
  • Another aspect of the present invention is a coated stent having a stent framework, the stent framework including areas of high strain, and a therapeutic coating disposed on at least a portion of the stent framework and avoiding the areas of high strain. The stent may further comprise an elastic coating disposed on at least the areas of high strain. [0009]
  • Yet another aspect of the present invention is a method of manufacturing a differentially coated stent. A stent framework is provided, the stent framework including areas of high strain. A therapeutic coating is applied to at least a portion of the stent framework, avoiding the areas of high strain. An elastic coating may be applied to at least the high-strain areas of stent framework either before or after the therapeutic coating is applied. [0010]
  • An additional aspect of the present invention is a system for producing a differentially coated stent, comprising means for providing a stent framework, the stent framework including areas of high strain, and means for applying a therapeutic coating to at least a portion of the stent framework, avoiding the areas of high strain. The system may further comprise means for applying an elastic coating to at least the areas of high strain [0011]
  • The aforementioned, and other features and advantages of the invention will become further apparent from the following detailed description of the presently preferred embodiments, read in conjunction with the accompanying drawings. The detailed description and drawings are merely illustrative of the invention rather than limiting, the scope of the invention being defined by the appended claims and equivalents thereof.[0012]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is an illustration of one embodiment of a system for treating a vascular condition, in accordance with the present invention; [0013]
  • FIG. 2 is an illustration of one embodiment of a differentially coated stent, in accordance with the present invention; [0014]
  • FIG. 3 is a flow diagram of one embodiment of a method of manufacturing a differentially coated stent, in accordance with the present invention; [0015]
  • FIG. 4 is a flow diagram of another embodiment of a method of manufacturing a differentially coated stent, in accordance with the present invention; [0016]
  • FIG. 5 is a flow diagram of another embodiment of a method of manufacturing a differentially coated stent, in accordance with the present invention.[0017]
  • DETAILED DESCRIPTION OF THE PRESENTLY PREFERRED EMBODIMENTS
  • One aspect of the present invention is a system for treating a vessel. One embodiment of the system, in accordance with the present invention, is illustrated in FIG. 1 at [0018] 100. System 100 comprises a catheter 110 and a stent 120 coupled to the catheter. Stent 120 includes a stent framework with areas of high strain 125. Stent 120 is differentially coated, with a therapeutic coating disposed on at least a portion of the stent framework and avoiding the areas of high strain. An elastic coating may be disposed on the areas that experience high strain.
  • Catheter [0019] 110 may include a balloon to expand the stent, or it may include a sheath that retracts to allow expansion of a self-expanding stent. Both types of catheter are well known in the art. Stent 120 is shown coupled to catheter 110 for delivery within a vessel.
  • The stent framework may be made of a wide variety of medical implantable materials, such as stainless steel, nitinol, tantalum, ceramic, nickel, titanium, aluminum, polymeric materials, MP35N, stainless steel, titanium ASTM F63-83 Grade 1, niobium, high carat gold K 19-22, or combinations of the above. [0020]
  • Areas of high strain [0021] 125 may be those areas of the stent framework that undergo deformation, for example when a stent is compressed onto a delivery catheter during manufacture or expanded during delivery. Coatings on high-strain areas of the stent framework may experience the same high strain as the stent framework. For this reason, these high-strain areas may be left uncoated or may be coated with an elastic coating that is capable of withstanding high strain without cracking, delaminating, or otherwise failing. Areas of the stent framework that do not experience high strain are coated with a therapeutic coating that may be selected for characteristics such as elution profile or durability rather than an ability to withstand high strain.
  • The therapeutic coating may include a therapeutic agent such as an antineoplastic agent, an antiproliferative agent, an antibiotic, an antithrombogenic agent, an anticoagulant, an antiplatelet agent, an anti-inflammatory agent, combinations of the above, and the like. The coating may be a polymer, including, but not limited to, urethane, polylactide (PLA), poly-l-lactic acid (PLLA), polyglycolic acid (PGA) polymer, poly (e-caprolactone) (PCL), polyacrylates, polymethacrylates, polycaprolactone (PCL), polymethylmethacrylate (PMMA), combinations and/or copolymers of the above, and the like. The specific polymer, polymer combinations or copolymers used may be adjusted as seen fit as required by the specific needs of the medical device and the drug used. [0022]
  • The elastic coating may be a polymer, including, but not limited to, urethane, polycaprolactone (PCL), polybutylmethacrylate (PBMA), polyethylenevinyl acetate (PEVA), combinations and/or copolymers of the above, and the like. The specific polymer, polymer combinations or copolymers used may be adjusted as required by the specific needs of the medical device and the drug used. The elastic coating may comprise a different polymer than that comprising the therapeutic coating. The elastic coating may include no therapeutic agent, or it may include a therapeutic agent that is the same as or different from the agent carried in the therapeutic coating. [0023]
  • Using the same therapeutic agent in both coatings may offer the benefit of delivering the therapeutic agent at different rates or different times. For example, the two coatings may display different elution characteristics, resulting in a drug being delivered at two rates; or they may have different durability characteristics, allowing the drug to be delivered by elution from one coating and being released through erosion from another. If the coatings contain different therapeutic agents, a benefit may be realized from the ability to simultaneously deliver more than one therapeutic agent. [0024]
  • Another aspect of the present invention is a differentially coated stent. One embodiment of the stent, in accordance with the present invention, is illustrated in FIG. 2 at [0025] 200. Stent 200 includes a stent framework 210 with areas of high strain 215. Stent 200 is differentially coated, with an elastic coating 220 disposed on the areas that experience high strain and a therapeutic coating 230 disposed on areas that experience low or no strain. Alternatively, the stent may be uncoated in the areas that experience high strain.
  • Stent framework [0026] 210 may be made of a wide variety of medical implantable materials, such as stainless steel, nitinol, tantalum, ceramic, nickel, titanium, aluminum, polymeric materials, MP35N, stainless steel, titanium ASTM F63-83 Grade 1, niobium, high carat gold K 19-22, or combinations of the above.
  • Areas of high strain [0027] 215 may be those areas of the stent framework that undergo deformation, for example when the stent is compressed onto a delivery catheter during manufacture or expanded during delivery. Coatings on high-strain areas of the stent framework may experience the same high strain as the stent framework. For this reason, these high-strain areas may be left uncoated or may be coated with an elastic coating 220 that is capable of withstanding high strain without cracking, delaminating, or otherwise failing. Areas of the stent framework that do not experience high strain are coated with a therapeutic coating 230. Elastic coating 220 and therapeutic coating 230 may comprise different polymers with different material properties. Because the therapeutic coating is not exposed to high strain, it may be selected for characteristics such as elution profile or durability rather than the ability to withstand high strain.
  • Therapeutic coating [0028] 230 may include a therapeutic agent such as an antineoplastic agent, an antiproliferative agent, an antibiotic, an antithrombogenic agent, an anticoagulant, an antiplatelet agent, an anti-inflammatory agent, combinations of the above, and the like. The coating may be a polymer, including, but not limited to, urethane, polycaprolactone (PCL), polymethylmethacrylate (PMMA), combinations of the above, and the like.
  • Elastic coating [0029] 220 may be a polymer, including, but not limited to, urethane, polycaprolactone (PCL), polybutylmethacrylate (PBMA), combinations of the above, and the like. The elastic coating may include no therapeutic agent, or it may include a therapeutic agent that is the same as or different from the agent carried in the therapeutic coating. Using the same therapeutic agent in both coatings may offer the benefit of delivering the therapeutic agent at different rates or different times. For example, the two coatings may display different elution characteristics, resulting in a drug being delivered at two rates; or they may have different durability characteristics, allowing the drug to be delivered by elution from one coating and being released through erosion from another. If the coatings contain different therapeutic agents, a benefit may be realized from the ability to simultaneously deliver more than one therapeutic agent.
  • A further aspect of the present invention is a method of manufacturing a differentially coated stent. FIG. 3 shows a flow diagram of one embodiment, in accordance with the present invention at [0030] 300.
  • In this embodiment, a stent framework is provided (Block [0031] 310). High-strain areas of the stent framework are masked by, for example, applying a narrow tetrafluorethylene sleeve over each area (Block 320). A therapeutic coating is then sprayed onto or otherwise applied to the stent framework (Block 330). The masking material is removed (Block 340). The areas carrying the therapeutic coating are then masked (Block 350), and an elastic coating is sprayed onto or otherwise applied to the areas of high strain (Block 360). Those skilled in the art will recognize that the high-strain areas may also be left uncoated.
  • FIG. 4 shows a flow diagram of another embodiment of a method of manufacturing a differentially coated stent, in accordance with the present invention at [0032] 400.
  • In this embodiment, a stent framework is provided (Block [0033] 410). The stent framework is coated with an elastic coating (Block 420). High-strain areas of the stent framework are then masked by, for example, applying a narrow tetrafluorethylene sleeve over each area (Block 430). A therapeutic coating is then sprayed onto or otherwise applied to the stent framework (Block 440). After coating, the masking material is removed (Block 450).
  • FIG. 5 shows a flow diagram of yet another embodiment of a method of manufacturing a differentially coated stent, in accordance with the present invention at [0034] 500.
  • A stent framework is provided (Block [0035] 510). High-strain areas of the stent framework are masked by coating with a protective polymer coating material such as Parylene (Block 520). The stent framework is then dipped into or otherwise exposed to a therapeutic coating (Block 530). The protective polymer coating material resists the therapeutic coating, resulting in the high-strain areas being coated with only the protective polymer.
  • While the embodiments of the invention disclosed herein are presently considered preferred, various changes and modifications can be made without departing from the spirit and scope of the invention. The scope of the invention is indicated in the appended claims, and all changes and modifications that come within the meaning and range of equivalents are intended to be embraced therein. [0036]

Claims (33)

What is claimed is:
1. A system for treating a vascular condition, comprising:
a catheter;
a stent coupled to the catheter, the stent including a stent framework, the stent framework including areas of high strain; and
a therapeutic coating disposed on at least a portion of the stent framework and avoiding the areas of high strain.
2. The system of claim 1 further comprising:
an elastic coating disposed on at least the high-strain areas of the stent framework.
3. The system of claim 2 wherein the therapeutic coating comprises a first polymer and the elastic coating comprises a second polymer.
4. The system of claim 1 wherein the therapeutic coating includes a therapeutic agent selected from a group consisting of an antineoplastic agent, an antiproliferative agent, an antibiotic, an antithrombogenic agent, an anticoagulant, an antiplatelet agent, and an anti-inflammatory agent.
5. The system of claim 2 wherein the elastic coating includes a therapeutic agent selected from a group consisting of an antineoplastic agent, an antiproliferative agent, an antibiotic, an antithrombogenic agent, an anticoagulant, an antiplatelet agent, and an anti-inflammatory agent.
6. The system of claim 2 wherein the therapeutic coating includes a first therapeutic agent and the elastic coating includes a second therapeutic agent.
7. The system of claim 2 wherein the therapeutic coating and the elastic coating display different elution characteristics.
8. The system of claim 2 wherein the therapeutic coating and the elastic coating display different durability characteristics.
9. The system of claim 1 wherein the catheter includes a balloon used to expand the stent.
10. The system of claim 1 wherein the catheter includes a sheath that retracts to allow expansion of the stent.
11. A differentially coated stent, comprising:
a stent framework, the stent framework including areas of high strain; and
a therapeutic coating disposed on at least a portion of the stent framework and avoiding the areas of high strain.
12. The stent of claim 11 further comprising:
an elastic coating disposed on at least the areas of high strain.
13. The stent of claim 11 wherein the therapeutic coating includes an agent selected from a group consisting of an antineoplastic agent, an antiproliferative agent, an antibiotic, an antithrombogenic agent, an anticoagulant, an antiplatelet agent, and an anti-inflammatory agent.
14. The stent of claim 12 wherein the elastic coating includes a therapeutic agent selected from a group consisting of an antineoplastic agent, an antiproliferative agent, an antibiotic, an antithrombogenic agent, an anticoagulant, an antiplatelet agent, and an anti-inflammatory agent.
15. The stent of claim 12 wherein the therapeutic coating includes a first therapeutic agent and the elastic coating includes a second therapeutic agent.
16. The stent of claim 12 wherein the therapeutic coating and the elastic coating display different elution characteristics.
17. The stent of claim 12 wherein the therapeutic coating and the elastic coating display different durability characteristics.
18. A method of manufacturing a differentially coated stent, comprising:
providing a stent framework, the stent framework including areas of high strain; and
applying a therapeutic coating to at least a portion of the stent framework, avoiding the areas of high strain.
19. The method of claim 18 wherein avoiding the areas of high strain comprises applying a therapeutic coating to only those areas of the stent framework that do not experience high strain.
20. The method of claim 18 wherein avoiding the areas of high strain comprises removing the therapeutic coating from high-strain areas of the stent framework.
21. The method of claim 18 wherein avoiding the areas of high strain comprises masking high-strain areas of the stent framework prior to applying a therapeutic coating.
22. The method of claim 21 wherein the stent framework is masked by one or more materials selected from a group consisting of a tetrafluorethylene sleeve, an adhesive-backed material, and a removable coating.
23. The method of claim 21 further comprising:
removing the masking material from the stent framework after the therapeutic coating is applied.
24. The method of claim 21 wherein the masking material is a protective polymer coating material.
25. The method of claim 24 wherein the protective polymer coating material is Parylene.
26. The method of claim 18 further comprising:
applying an elastic coating to at least the high-strain areas of the stent framework after applying the therapeutic coating.
27. The method of claim 26 further comprising:
masking the portion of the stent framework to which the therapeutic coating has been applied prior to applying the elastic coating.
28. The method of claim 18 further comprising:
applying an elastic coating to at least the high-strain areas of the stent framework prior to applying a therapeutic coating.
29. The method of claim 28 further comprising:
masking high-strain areas of the stent framework prior to applying the therapeutic coating.
30. The method of claim 18 wherein the therapeutic coating is applied by a method selected from the group consisting of pad printing, inkjet printing, rolling, painting, spraying, micro-spraying, dipping, wiping, electrostatic deposition, vapor deposition, epitaxial growth, and combinations thereof.
31. The methods of claims 26 and 28 wherein the elastic coating is applied by a method selected from the group consisting of pad printing, inkjet printing, rolling, painting, spraying, micro-spraying, dipping, wiping, electrostatic deposition, vapor deposition, epitaxial growth, and combinations thereof.
32. A system for producing a differentially coated stent, comprising:
means for providing a stent framework, the stent framework including areas of high strain; and
means for applying a therapeutic coating to at least a portion of the stent framework, avoiding the areas of high strain.
33. The system of claim 32 further comprising:
means for applying an elastic coating to at least the areas of high strain.
US10/350,704 2003-01-24 2003-01-24 Differentially coated stent Abandoned US20040147998A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/350,704 US20040147998A1 (en) 2003-01-24 2003-01-24 Differentially coated stent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/350,704 US20040147998A1 (en) 2003-01-24 2003-01-24 Differentially coated stent
US11/555,845 US7540880B2 (en) 2003-01-24 2006-11-02 Differentially coated stent

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US11/555,845 Division US7540880B2 (en) 2003-01-24 2006-11-02 Differentially coated stent
US11/555,845 Continuation-In-Part US7540880B2 (en) 2003-01-24 2006-11-02 Differentially coated stent

Publications (1)

Publication Number Publication Date
US20040147998A1 true US20040147998A1 (en) 2004-07-29

Family

ID=32735626

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/350,704 Abandoned US20040147998A1 (en) 2003-01-24 2003-01-24 Differentially coated stent
US11/555,845 Active 2023-07-13 US7540880B2 (en) 2003-01-24 2006-11-02 Differentially coated stent

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/555,845 Active 2023-07-13 US7540880B2 (en) 2003-01-24 2006-11-02 Differentially coated stent

Country Status (1)

Country Link
US (2) US20040147998A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004063794A1 (en) * 2004-12-30 2006-07-13 Universität Duisburg-Essen implant
US20070260300A1 (en) * 2006-05-04 2007-11-08 Daniel Gregorich Intraluminal medical device having a curable coating
DE102006038239A1 (en) * 2006-08-07 2008-02-14 Biotronik Vi Patent Ag Medical implant for animals and humans comprises an implant base body completely or partially covered with a polymer matrix containing active ingredients and made from one or more polymers
WO2008124309A1 (en) * 2007-04-05 2008-10-16 Medtronic Vascular Inc. Stent with therapeutic agent delivery structures in low strain regions
US20100161039A1 (en) * 2008-12-23 2010-06-24 Vipul Dave Adhesion promoting temporary mask for coated surfaces
US7803180B2 (en) 2005-04-04 2010-09-28 Flexible Stenting Solutions, Inc. Flexible stent
US20100244329A1 (en) * 2004-08-31 2010-09-30 Hossainy Syed F A Medical Device with Regioselective Structure-Property Distribution
US20110066225A1 (en) * 2009-09-17 2011-03-17 Mikael Trollsas Bioabsorbable Stent With Time Dependent Structure And Properties And Regio-Selective Degradation
US20110066223A1 (en) * 2009-09-14 2011-03-17 Hossainy Syed F A Bioabsorbable Stent With Time Dependent Structure And Properties
US8500794B2 (en) 2007-08-02 2013-08-06 Flexible Stenting Solutions, Inc. Flexible stent
CN104224412A (en) * 2014-08-20 2014-12-24 湖南英捷高科技有限责任公司 Method for preparing intravascular stent upon 3D (three-dimensional) printing technology
US9149376B2 (en) 2008-10-06 2015-10-06 Cordis Corporation Reconstrainable stent delivery system
US9254212B2 (en) 2012-04-06 2016-02-09 Abbott Cardiovascular Systems Inc. Segmented scaffolds and delivery thereof for peripheral applications

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169178B1 (en) * 2002-11-12 2007-01-30 Advanced Cardiovascular Systems, Inc. Stent with drug coating
GB0615658D0 (en) * 2006-08-07 2006-09-13 Angiomed Ag Hand-held actuator device
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
AU2009293019A1 (en) 2008-09-19 2010-03-25 Tandem Diabetes Care Inc. Solute concentration measurement device and related methods
US9283305B2 (en) 2009-07-09 2016-03-15 Medtronic Vascular, Inc. Hollow tubular drug eluting medical devices
AU2010278894B2 (en) 2009-07-30 2014-01-30 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US8678046B2 (en) 2009-09-20 2014-03-25 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8828474B2 (en) 2009-09-20 2014-09-09 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US8381774B2 (en) * 2009-09-20 2013-02-26 Medtronic Vascular, Inc. Methods for loading a drug eluting medical device
US20110070358A1 (en) 2009-09-20 2011-03-24 Medtronic Vascular, Inc. Method of forming hollow tubular drug eluting medical devices
US8616040B2 (en) 2010-09-17 2013-12-31 Medtronic Vascular, Inc. Method of forming a drug-eluting medical device
US8333801B2 (en) 2010-09-17 2012-12-18 Medtronic Vascular, Inc. Method of Forming a Drug-Eluting Medical Device
US8632846B2 (en) 2010-09-17 2014-01-21 Medtronic Vascular, Inc. Apparatus and methods for loading a drug eluting medical device
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
JP5960849B2 (en) * 2013-01-30 2016-08-02 テルモ株式会社 Biological luminal cavity treatment system and the stent
US9486340B2 (en) 2013-03-14 2016-11-08 Medtronic Vascular, Inc. Method for manufacturing a stent and stent manufactured thereby
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
US9114032B1 (en) 2014-05-21 2015-08-25 Medtronic Vascular, Inc. Method of making a stent

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739762A (en) * 1985-11-07 1988-04-26 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US5292331A (en) * 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
US5421955A (en) * 1991-10-28 1995-06-06 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
US6090127A (en) * 1995-10-16 2000-07-18 Medtronic, Inc. Medical stents, apparatus and method for making same
US20030050689A1 (en) * 1999-03-05 2003-03-13 Surgica Corporation Surface-modified bioactive suppressant surgical implants
US20030139801A1 (en) * 2000-12-22 2003-07-24 Avantec Vascular Corporation Delivery of therapeutic capable agents
US20040106975A1 (en) * 2001-03-20 2004-06-03 Gmp/Cardiac Care, Inc. Rail stent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7344560B2 (en) * 2004-10-08 2008-03-18 Boston Scientific Scimed, Inc. Medical devices and methods of making the same
US20070027530A1 (en) * 2005-07-26 2007-02-01 Medtronic Vascular, Inc. Intraluminal device, catheter assembly, and method of use thereof
EP2084310A1 (en) * 2006-10-05 2009-08-05 Boston Scientific Limited Polymer-free coatings for medical devices formed by plasma electrolytic deposition

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739762A (en) * 1985-11-07 1988-04-26 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4739762B1 (en) * 1985-11-07 1998-10-27 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US5292331A (en) * 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
US5421955A (en) * 1991-10-28 1995-06-06 Advanced Cardiovascular Systems, Inc. Expandable stents and method for making same
US5421955B1 (en) * 1991-10-28 1998-01-20 Advanced Cardiovascular System Expandable stents and method for making same
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
US6090127A (en) * 1995-10-16 2000-07-18 Medtronic, Inc. Medical stents, apparatus and method for making same
US20030050689A1 (en) * 1999-03-05 2003-03-13 Surgica Corporation Surface-modified bioactive suppressant surgical implants
US20030139801A1 (en) * 2000-12-22 2003-07-24 Avantec Vascular Corporation Delivery of therapeutic capable agents
US20040106975A1 (en) * 2001-03-20 2004-06-03 Gmp/Cardiac Care, Inc. Rail stent

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8366762B2 (en) * 2004-08-31 2013-02-05 Advanced Cardiovascular Systems, Inc. Method of making a medical device with regioselective structure-property distribution
US20100244329A1 (en) * 2004-08-31 2010-09-30 Hossainy Syed F A Medical Device with Regioselective Structure-Property Distribution
US8623069B2 (en) 2004-08-31 2014-01-07 Advanced Cardiovascular Systems, Inc. Medical device with regioselective structure-property distribution
DE102004063794A1 (en) * 2004-12-30 2006-07-13 Universität Duisburg-Essen implant
US7803180B2 (en) 2005-04-04 2010-09-28 Flexible Stenting Solutions, Inc. Flexible stent
US9592137B2 (en) 2005-04-04 2017-03-14 Flexible Stenting Solutions, Inc. Flexible stent
US20070260300A1 (en) * 2006-05-04 2007-11-08 Daniel Gregorich Intraluminal medical device having a curable coating
DE102006038239A1 (en) * 2006-08-07 2008-02-14 Biotronik Vi Patent Ag Medical implant for animals and humans comprises an implant base body completely or partially covered with a polymer matrix containing active ingredients and made from one or more polymers
WO2008124309A1 (en) * 2007-04-05 2008-10-16 Medtronic Vascular Inc. Stent with therapeutic agent delivery structures in low strain regions
US8500794B2 (en) 2007-08-02 2013-08-06 Flexible Stenting Solutions, Inc. Flexible stent
US9149376B2 (en) 2008-10-06 2015-10-06 Cordis Corporation Reconstrainable stent delivery system
US10010438B2 (en) 2008-10-06 2018-07-03 Flexible Stenting Solutions, Inc. Reconstrainable stent delivery system
EP2201915A1 (en) * 2008-12-23 2010-06-30 Cordis Corporation Adhesion promoting temporary mask for coated surfaces
US20100304007A1 (en) * 2008-12-23 2010-12-02 Vipul Dave Adhesion promoting temporary mask for coated surfaces
US20100161039A1 (en) * 2008-12-23 2010-06-24 Vipul Dave Adhesion promoting temporary mask for coated surfaces
US8927049B2 (en) 2008-12-23 2015-01-06 Cordis Corporation Adhesion promoting temporary mask for coated surfaces
US20110066223A1 (en) * 2009-09-14 2011-03-17 Hossainy Syed F A Bioabsorbable Stent With Time Dependent Structure And Properties
US20110066225A1 (en) * 2009-09-17 2011-03-17 Mikael Trollsas Bioabsorbable Stent With Time Dependent Structure And Properties And Regio-Selective Degradation
US20150182360A1 (en) * 2009-09-17 2015-07-02 Abbott Cardiovascular Systems Inc. Method of treatment with a bioabsorbable stent with time dependent structure and properties and regio-selective degradation
US9289318B2 (en) * 2009-09-17 2016-03-22 Abbott Cardiovascular Systems Inc. Method of treatment with a bioabsorbable stent with time dependent structure and properties and regio-selective degradation
US8425587B2 (en) 2009-09-17 2013-04-23 Abbott Cardiovascular Systems Inc. Method of treatment with a bioabsorbable stent with time dependent structure and properties and regio-selective degradation
US9254212B2 (en) 2012-04-06 2016-02-09 Abbott Cardiovascular Systems Inc. Segmented scaffolds and delivery thereof for peripheral applications
US9895244B2 (en) 2012-04-06 2018-02-20 Abbott Cardiovascular Systems Inc. Segmented scaffolds and delivery thereof for peripheral applications
CN104224412A (en) * 2014-08-20 2014-12-24 湖南英捷高科技有限责任公司 Method for preparing intravascular stent upon 3D (three-dimensional) printing technology

Also Published As

Publication number Publication date
US20070061007A1 (en) 2007-03-15
US7540880B2 (en) 2009-06-02

Similar Documents

Publication Publication Date Title
EP1518517B1 (en) Drug-delivery endovascular stent
JP4347044B2 (en) Device for delivering a therapeutic agent having a variable release profile
US8057813B2 (en) Multiple drug delivery from a balloon and a prosthesis
US8152841B2 (en) Medical devices including metallic films
US6471980B2 (en) Intravascular delivery of mycophenolic acid
US7955371B2 (en) System and method for stent deployment and infusion of a therapeutic agent into tissue adjacent to the stent ends
US5578075A (en) Minimally invasive bioactivated endoprosthesis for vessel repair
CA2644703C (en) Intravascular device with netting system
US7169173B2 (en) Composite stent with regioselective material and a method of forming the same
AU758175B2 (en) Polymeric coatings with controlled delivery of active agents
US7077859B2 (en) Apparatus and methods for variably controlled substance delivery from implanted prostheses
EP1517713B1 (en) Stent coatings with sustained drug release rate
US20030216806A1 (en) Stent
US6059810A (en) Endovascular stent and method
US20010001824A1 (en) Chamber for applying therapeutic substances to an implantable device
US7955383B2 (en) Laminated implantable medical device having a metallic coating
US5651174A (en) Intravascular radially expandable stent
CA2657682C (en) Stent
EP1466634B1 (en) Drug-eluting stent for controlled drug delivery
US20020133221A1 (en) Expandable intraluminal graft
US20070281117A1 (en) Use of plasma in formation of biodegradable stent coating
US7575632B2 (en) Reflowed drug-polymer coated stent and method thereof
US7682387B2 (en) Drug-delivery endovascular stent and method for treating restenosis
US20040024450A1 (en) Drug-delivery endovascular stent and method for treating restenosis
EP1467680B1 (en) Stent bumper struts

Legal Events

Date Code Title Description
AS Assignment

Owner name: MEDTRONIC AVE, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NOLTING, JOHN E.;REEL/FRAME:014087/0217

Effective date: 20030514